Drug Trial Radar · NCT06846398
A Phase 2 in Adult Subjects With Hereditary Angioedema
Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
25
Actual
Start
Feb 28, 2025
Primary completion
Jun 30, 2026
Study completion Mar 30, 2028
Sponsor
- Lead sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 in Adult Subjects with Hereditary Angioedema
Conditions
- Hereditary Angioedema (HAE)
Interventions
BW-20805Drug
SC administrations of BW-20805 600 mg on Day1 to Day673
BW-20805Drug
SC administrations of BW-20805 300 mg every 24 weeks on Day1 to Day169;Day337 to Day673
BW-20805Drug
SC administrations of BW-20805 300 mg every 12 weeks on Day 1 to Day 589
Primary outcomes
What the sponsor says the trial is designed to measure.
- To determine the prophylactic effect of in HAE attack rate.Time frame: from baseline to Day169
Locations
18 sites in 6 countries. Site status is shown where the registry gives one.
Institute for Asthma and Allergy - Wheaton
Silver Spring, Maryland
Washington University School of Medicine
St Louis, Missouri
Duke University Medicine Center
Durham, North Carolina
Penn State Milton S. Hershey MC - Penn State
Hershey, Pennsylvania
Inova Clinical Trials and Research Center
Falls Church, Virginia
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
West China Hospital, Sichuan University
Chengdu, Sichaun, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Universitätsmedizin der Johannes Gutenberg
Mainz, Rhineland-Palatinate, Germany
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco
Catania, Catania, Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, Florence, Italy
Azienda Ospedale - Universita di Padova
Padova, PD, Italy
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Lesser Poland Voivodeship, Poland
Hospital Universitario Virgen del Rocío
Seville, Sevilla, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.